Radcliffe Capital Management’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-139,840
| Closed | -$12.2K | – | 170 |
|
|
2023
Q4 | $12.2K | Sell |
139,840
-127,790
| -48% | -$11.2K | ﹤0.01% | 131 |
|
|
2023
Q3 | $42.8K | Sell |
267,630
-21,199
| -7% | -$3.39K | 0.01% | 211 |
|
|
2023
Q2 | $24.6K | Hold |
288,829
| – | – | ﹤0.01% | 308 |
|
|
2023
Q1 | $18.9K | Hold |
288,829
| – | – | ﹤0.01% | 435 |
|
|
2022
Q4 | $2.9M | Hold |
288,829
| – | – | 0.09% | 352 |
|
|
2022
Q3 | $2.85M | Hold |
288,829
| – | – | 0.07% | 488 |
|
|
2022
Q2 | $2.83M | Hold |
288,829
| – | – | 0.07% | 516 |
|
|
2022
Q1 | $2.83M | Hold |
288,829
| – | – | 0.06% | 493 |
|
|
2021
Q4 | $2.81M | Hold |
288,829
| – | – | 0.07% | 422 |
|
|
2021
Q3 | $2.81M | Hold |
288,829
| – | – | 0.08% | 364 |
|
|
2021
Q2 | $2.78M | Buy |
+288,829
| New | +$2.78M | 0.09% | 379 |
|